NEW YORK , Nov. 13, 2024 /PRNewswire/ -- Report on how AI is driving market transformation - The global DNA sequencing market size is estimated to grow by USD 17.34 billion from 2024-2028, according to Technavio.
The market is estimated to grow at a CAGR of over 20.01% during the forecast period. Growing adoption of ngs is driving market growth, with a trend towards emergence of third-generation sequencing methods.
However, inadequate resources for dna sequencing in developing countries poses a challenge.Key market players include 10X Genomics Inc., Abbott Laboratories, Agilent Technologies Inc.
, Azenta Inc., Becton Dickinson and Co., BGI Genomics Co.
Ltd., Bio Rad Laboratories Inc., Danaher Corp.
, Eurofins Scientific SE, F. Hoffmann La Roche Ltd., Illumina Inc.
, Laboratory Corp. Of America Holdings, Macrogen Inc., Merck KGaA, Pacific Biosciences of California Inc.
, PerkinElmer Inc., QIAGEN NV, SeqLL Inc., Tecan Trading AG, and Thermo Fisher Scientific Inc.
. Key insights into market evolution with AI-powered analysis. Explore trends, segmentation, and growth drivers- View Free Sample PDF Market Driver The DNA sequencing market is experiencing significant growth due to the emergence of third-generation sequencing technology.
This advanced method reads DNA at the single-molecule level, eliminating the need for clonal amplification and preparative steps. Third-generation sequencing offers long-reads, whole-transcript sequencing, and epigenetic modification detection. Challenges,.
